On
February 14, Shanghe Economic Development Zone held the 2024 Economic Work
Conference to summarize the regional development achievements and deploy key
tasks in the new stage, commending outstanding advanced enterprises and
individuals. Keyuan Pharma won the "Outstanding Contribution Award"
and "Science and Technology Talent Award" with outstanding industrial
contribution and innovation strength. Hongsheng Jiang, chairman of Keyuan
Pharma, was appointed as the "Ambassador of Investment Promotion",
demonstrating the benchmark role of government-enterprise collaboration.
As
a listed company in the domestic pharmaceutical industry, Keyuan Pharma has
continued to increase R&D investment and build a deep integration platform
for industry, academia and research. Core products cover hypoglycemic,
cardiovascular and other major disease areas. Since its establishment, Keyuan
Pharma has actively practiced social responsibility, driven the industrial
upgrading of Shanghe Economic Development Zone with scientific and
technological innovation, and annual tax contribution ranked in the forefront,
helping to deeply integrate the high-quality development of the regional
economy with social benefits. This award marks that Keyuan Pharma's
"Science and Technology + Talent" strategy authoritatively recognized
again.
It
is worth noting that Hongsheng Jiang, Chairman of Keyuan Pharma, was appointed
as the "Ambassador of Investment Promotion". Mr. Jiang will take on
the task of promoting the development zone in the future, attracting more
high-quality enterprises and projects to settle and jointly promote the
prosperity of the regional economy.
Keyuan
Pharma will continue to practice responsibility and commitment, deepen
scientific and technological innovation, strengthen talent development, expand international
cooperation, and continuously enhance the comprehensive competitiveness, and
contribute more to the prosperity of Shanghe Economic Development Zone.